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Abstract
The objective of the present study was to assess the incidence, risk
factors and outcome of patients who develop acute renal failure (ARF)
in intensive care units. In this prospective observational study, 221
patients with a 48-h minimum stay, 18-year-old minimum age and
absence of overt acute or chronic renal failure were included. Exclu-
sion criteria were organ donors and renal transplantation patients.
ARF was defined as a creatinine level above 1.5 mg/dL. Statistics
were performed using Pearsons’ χ2 test, Student t-test, and Wilcoxon
test. Multivariate analysis was run using all variables with P < 0.1 in
the univariate analysis. ARF developed in 19.0% of the patients, with
76.19% resulting in death. Main risk factors (univariate analysis)
were: higher intra-operative hydration and bleeding, higher death risk
by APACHE II score, logist organ dysfunction system on the first day,
mechanical ventilation, shock due to systemic inflammatory response
syndrome (SIRS)/sepsis, noradrenaline use, and plasma creatinine
and urea levels on admission. Heart rate on admission (OR = 1.023
(1.002-1.044)), male gender (OR = 4.275 (1.340-13642)), shock due
to SIRS/sepsis (OR = 8.590 (2.710-27.229)), higher intra-operative
hydration (OR = 1.002 (1.000-1004)), and plasma urea on admission
(OR = 1.012 (0.980-1044)) remained significant (multivariate analy-
sis). The mortality risk factors (univariate analysis) were shock due to
SIRS/sepsis, mechanical ventilation, blood stream infection, potas-
sium and bicarbonate levels. Only potassium levels remained signifi-
cant (P = 0.037). In conclusion, ARF has a high incidence, morbidity
and mortality when it occurs in intensive care unit. There is a very
close association with hemodynamic status and multiple organ dys-
function.
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Introduction
Despite the recent technological advances,
there is still a high incidence of acute renal
failure (ARF) in intensive care unit (ICU)
leading to high mortality (1-6). ARF can be
defined as a sudden and continuous decrease
of glomerular function associated with
azotemia, followed or not by decreased uri-
nary output (7). It occurs mostly as part of a
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multiple organ dysfunction syndrome asso-
ciated with the systemic inflammatory re-
sponse syndrome (SIRS) and sepsis, but it
can also occur as a separate event. Its inci-
dence varies from 3 to 30% (4,8-11) with
mortality ranging from 36 to 90% (1-4,11,
12), depending on the type of ICU or type of
patient assessed and the period during which
the study is conducted. One of the factors
that contribute to this high incidence and
mortality is the greater morbidity of the pa-
tients currently admitted to ICU. Due to the
better diagnostic and therapeutic resources
available today, elderly patients and others
with important co-morbidities, such as im-
munosuppression and chronic organ dysfunc-
tions, undergo more aggressive treatments.
Several risk factors involved in the gene-
sis of ARF have been analyzed in the medi-
cal literature. Obstetric bleeding and diges-
tive hemorrhage, proposed by several inves-
tigators in earlier studies (5-8), have given
way to consideration of other factors such as
sepsis, shock, infections, use of contrast, and
drug toxicity (4,5,8,13,14). Other associated
factors are congestive heart failure and acute
myocardial infarction (4,15,16), cirrhosis (4),
chemotherapy (4), large burns (4), poly-
trauma, mostly associated with rhabdomy-
olysis, and surgery (17,18), mainly, com-
plex heart and vascular surgeries (6). Me-
chanical ventilation is a frequently reported
factor (19), probably as a marker of multiple
organ dysfunction syndrome.
Similarly, the risk factors for mortality
are also multiple in patients with ARF. Stud-
ies have demonstrated the importance of age
and male gender, the latter possibly due to
preexistent vascular diseases (1,3,4,6,10,13,
20-23). The delay before ARF onset, Acute
Physiology, Age and Chronic Health Evalu-
ation II (APACHE II) score and length of
stay in the ICU seem to be important, prob-
ably because they are markers of the severity
of the patient’s condition (24).
The objective of the present study was to
evaluate the incidence of ARF among ICU
patients with normal renal function on ad-
mission, as assessed by creatinine levels,
and to analyze the risk and prognostic fac-
tors of ARF and its impact on the clinical
course as well as the mortality of these pa-
tients.
Patients and Methods
This was a prospective observational
study conducted in a general ICU of a ter-
tiary care university hospital. From October
1, 1999 to September 30, 2000, 828 patients
were admitted to the ICU and only 221
satisfied both the inclusion and exclusion
criteria. They were assessed prospectively
once they met all the inclusion criteria, such
as 48-h minimum stay, plasma creatinine
levels of 1.5 mg/dL or lower, and minimum
age of 18 years. Organ donors and renal
transplant recipients were excluded.
The study was approved by the Ethics
Committee of Hospital São Paulo.
On admission, demographic data were
collected (gender and age), as well as cat-
egory of admission (clinical, emergency
surgical or elective surgical patients), cause
of admission (infected or non-infected clini-
cal patients and type of surgery), physi-
ologic variables (heart rate, mean arterial
pressure and central venous pressure), first
24-h stay water balance and APACHE II
score with their respective death risk (25)
and prior admission data (chronic diseases
and previous length of hospital stay). Intra-
operative data, such as surgery duration,
surgical complications (bleeding, hypoten-
sion, hypoxemia, and acidemia), urinary out-
put and hydration volume, as the total vol-
ume administered during surgery, were also
recorded.
To quantify organ dysfunction, the logis-
tic organ dysfunction system (LODS) score
(26) was used on the first and seventh days.
Laboratory evaluation was performed daily
and included acid-base balance, sodium, po-
tassium, urea, creatinine, hemogram, and
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coagulogram. Risk factors included use of
radiocontrast media, nephrotoxic and vaso-
active drugs before ARF onset, mechanical
ventilation and occurrence of SIRS/sepsis,
shock due to SIRS/sepsis, acute lung injury,
and acute respiratory distress syndrome. Pa-
tients were followed until ICU discharge or
death.
ARF was defined as a creatinine level
above 1.5 mg/dL. Patients who developed
ARF were monitored for total water balance,
duration of ARF episode, plasma bicarbo-
nate levels, need for dialysis, and use of a
diuretic in order to complete the evaluation
of prognostic factors. Standard treatment of
ARF and criteria to start renal replacement
therapy were not protocolled or recorded.
All clinical decisions were made by the at-
tending physician.
Statistical analysis was performed using
an SAS 6.12 database. Quantitative vari-
ables are reported as means ± SD and quali-
tative variables as percentage. In the univar-
iate analysis of risk factors we used the
Student t-test or Wilcoxon test for the quan-
titative variables and the Pearsons’ χ2 test
for the qualitative ones. All variables with a
P value <0.1 in the univariate analysis were
selected for multivariate analysis. The logis-
tic regression forward method was used for
multivariate analysis of the risk factor, and
its results are reported as odds ratio (OR) and
confidence interval. The logistic regression
method could not be used to analyze the
prognostic factors due to the instability of
the model. Therefore, discriminating analy-
sis was performed, with the level of signifi-
cance set at P < 0.05.
Results
Global data of the study population
The demographic and overall features of
the study population are shown in Table 1.
ARF occurred in 42 patients (19%) of the
study population.
Risk factors for acute renal failure
development
There was no significant difference in
mean age between patients with and without
ARF (55.3 ± 18.4 (20-85) years and 54.7 ±
19.4 (18-94) years, respectively), with P =
0.873. We observed a trend towards an in-
creasing number of ARF cases among male
patients compared to female patients (59.5
and 40.5%, respectively, with P = 0.053).
Although this difference was not statisti-
cally significant in univariate analysis, it
was one of the significant variables in multi-
Table 1. General characteristics of the 221 pa-
tients studied.
Age (years) 54.8 ± 19.2
Gender
Female 119 (53.8%)
Male 102 (46.2%)
Chronic diseases
All 141 (63.8%)
Hypertension 79 (35.7%)
Diabetes mellitus 31 (14.0%)
Coronary heart disease 18 (8.1%)
Category of admission
Clinical 61 (27.6%)
Emergency surgery 62 (28.1%)
Elective surgery 98 (44.3%)
Type of surgery
Neurosurgery 45 (20.4%)
Gastrosurgery 36 (16.3%)
Vascular surgery 22 (9.9%)
Surgical complicationsa
All 50 (22.6%)
Hypotension 38 (17.2%)
Bleeding 29 (13.1%)
APACHE II score 15.2 ± 7.7
Death risk 14.8 ± 17.4
1st day LODS score 5.3 ± 3.0
7th day LODS score 6.9 ± 4.7
Acute renal failure 19.0%
Mortality 36.2%
Data are reported as means ± SD or as number of
patients, with percent given in parentheses. All
percentages refer to the total number of patients
(N = 221). Only main categories are presented,
and therefore the sum is not 100%. aA patient
could have had more than one complication.
APACHE II = Acute Physiology, Age and Chronic
Health Evaluation II; LODS = logistic organ dys-
function system.
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and acute myocardial infarction were also
more frequent in males than in females (11.8
vs 5.0%, with P = 0.068 and 6.9 vs 0.8%,
with P = 0.019, respectively).
The mean hospital stay before ICU ad-
mission of ARF patients was longer than that
of non-ARF patients (8.6 ± 8.2 (0-31) days
vs 6.9 ± 10.1 (0-55) days, with P = 0.044).
Surgical complications, namely bleeding and
hypotension, were both more frequent among
ARF patients (34.4 and 37.5% in ARF pa-
tients vs 14.2 and 20.5% in non-ARF pa-
tients, P = 0.008 and 0.04, respectively).
Intraoperative hydration was also related to
ARF development (P = 0.01; Table 2).
Organ dysfunction severity assessed by
the LODS score on the first day of stay
correlated with ARF development (6.5 ± 3.5
- ARF patients vs 5.0 ± 2.9 - non-ARF
patients, P = 0.006). However, when we
used the APACHE II score this correlation
was not very clear (17.5 ± 9.4 - ARF patients
vs 14.6 ± 7.1 - non-ARF patients, P = 0.073),
although the death risk was significantly
higher in the ARF population (20.9 ± 23.1 -
ARF patients vs 13.2 ± 15.2 - non-ARF
patients, P = 0.006). Plasma creatinine and
urea levels on admission were higher in the
ARF population (1.0 ± 0.3 (0.3-1.5) and
41.4 ± 19.0 (15.0-84.0) mg/dL) compared to
non-ARF patients (0.9 ± 0.3 (0.2-1.5) and 34.9
± 19.5 (10.0-128.0) mg/dL), with P = 0.0007
and 0.048, respectively. SIRS/sepsis, shock
due to SIRS/sepsis and respiratory failure re-
quiring mechanical ventilation were associ-
ated with ARF development (Table 2).
Only the previous use of noradrenaline
correlated with the development of ARF
(39.5 and 17.9%, ARF and non-ARF pa-
tients, respectively, with P = 0.003). Regard-
ing nephrotoxic drugs, only the use of
radiocontrast media was significantly more
frequent among ARF patients (9.5%) com-
pared to the non-ARF ones (1.7%), with P =
0.026. The univariate analysis of risk factors
is presented in Table 2.
In multivariate analysis the variables that
variate analysis. Other significant differences
between males and females could explain
this finding. There was a higher number of
surgical complications in males (28.4 and
17.6%, respectively, with P = 0.002), in-
cluding hypotension (23.5 vs 11.8%, with P
= 0.033) and bleeding (17.6 and 9.2%, with
P = 0.065). Previous coronary heart disease
Table 2. Univariate analysis of risk factors for the development of acute renal failure
(ARF).
Characteristics ARF patients Non-ARF patients P
Male gender 25 (59.5%) 77 (43.0%) 0.053
Surgical complications 15 (46.5%) 35 (27.6%) 0.035
Bleeding 11 (34.4%) 18 (14.2%) 0.008
Hypotension 12 (37.5%) 26 (20.5%) 0.04
SIRS/sepsis 30 (78.9%) 75 (41.9%) 0.0001
Shock due to SIRS/sepsis 21 (50.0%) 30 (16.8%) 0.0001
Use of noradrenaline 15 (39.5%) 32 (17.9%) 0.003
Use of radiologic contrast 4 (9.5%) 3 (1.7%) 0.026
Respiratory failure 33 (86.8%) 99 (55.3%) 0.001
Previous length of stay (days) 8.6 ± 8.2 6.9 ± 10.1 0.044
LODS score 6.5 ± 3.5 5.02 ± 2.9 0.006
APACHE II score 17.49 ± 9.37 14.59 ± 7.14 0.073
Death risk (%) 20.95 ± 23.14 13.19 ± 15.24 0.049
Urea on admission (mg/dL) 41.36 ± 18.98 34.93 ± 19.46 0.048
Creatinine on admission (mg/dL) 1.04 ± 0.29 0.88 ± 0.26 0.0007
Intraoperative hydration (mL/kg) 124.23 ± 117.83 95.31 ± 173.26 0.0170
Chronic diseases
Hypertension 15 (35.7%) 64 (35.7%) NS
Diabetes mellitus 7 (16.7%) 24 (13.4%) NS
Coronary heart disease 6 (14.3%) 12 (6.7%) NS
COPD 2 (4.8%) 11 (6.1%) NS
Admission category
Clinical 10 (23.8%) 51 (28.5%) NS
Elective surgery 21 (50.0%) 77 (43.0%) NS
Emergency surgery 11 (26.2%) 51 (28.5%) NS
Nephrotoxic drugs
Aminoglycosides 17 (40.5%) 58 (32.4%) NS
Vancomycin 14 (33.3%) 54 (30.2%) NS
Vasoactive drugs
Dobutamine 6 (15.8%) 12 (6.7%) NS
Dopamine 15 (39.5%) 14 (25.1%) NS
Surgery characteristics
Length (min) 325.5 ± 183.3 276.1 ± 160.2 NS
Urinary output (mL kg-1 h-1) 4.5 ± 6.2 5.2 ± 7.6 NS
Age (years) 55.3 ± 18.4 54.7 ± 19.4 NS
Data were analyzed statistically by the Pearsons’ χ2 test and the Student t-test. Data
are reported as means ± SD or as number of patients, with percent given in parenthe-
ses. SIRS = systemic inflammatory response syndrome; LODS = logistic organ dys-
function system; APACHE II = Acute Physiology, Age and Chronic Health Physiology
Evaluation II; COPD = chronic obstructive pulmonary disease. All variables with P <
0.1 were selected for multivariate analysis. NS = not significant.
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remained independently associated with ARF
development are listed in Table 3. In the
surgical subgroup analysis the same vari-
ables have been found (Table 3).
Clinical outcome
During the ICU stay the mortality of
ARF patients (76.2%) was significantly
higher than that of non-ARF patients (27.0%),
with P = 0.018. There was also a significant
increase of ICU length of stay in the first
group (16.1 ± 13.3 vs 12.7 ± 14.9 days, P =
0.018).
Patients developed ARF after a mean of
5.8 ± 7.7 (2-41) days of ICU stay. Creatinine
levels remained high for a mean period of
7.8 ± 8.4 (2-33) days and mean peak levels
were 3.3 ± 1.8 (1.6-9.1) mg/dL. Among 42
patients with ARF, 41 (97.6%) had at least
one complication while in the group without
ARF the rate reached 73.2% (P = 0.001).
The most frequent complications can be seen
in Table 4.
Organ dysfunction, when assessed by
LODS score on the seventh day, was more
severe in patients with ARF (10.8 ± 4.8 (4-22)
vs 6.1 ± 4.3 (0-17), P = 0.0001). The accumu-
lated water balance was higher in patients with
ARF (78.6%) than in those without it (54.2%),
with P = 0.004. Only 10 patients (23.8%)
needed renal replacement therapy and all of
these received hemodialysis.
Analysis of  risk factors for mortality in acute
renal failure patients
Univariate analysis showed that the pres-
ence of shock due to SIRS/sepsis, respira-
tory failure requiring mechanical ventila-
tion, plasma bicarbonate levels, and potas-
sium levels correlated with mortality (Table
5). The variables that did not correlate with
mortality are also shown in Table 5. In the
discriminating analysis, only potassium lev-
els remained as a risk factor for mortality,
with P = 0.037.
Discussion
The definition of ARF is not uniform in
the medical literature. Most studies, even the
latest ones, have used biochemical criteria
based on plasma creatinine levels, whereas
others were based on the need for dialysis
(1-4,6,7). Kidney tomography or biopsy has
also been used (1). This heterogeneity of
criteria makes the comparison among stud-
ies extremely difficult (27). The criterion
Table 4. Incidence of complications during the stay in the intensive care unit.
Complications ARF patients Non-ARF patients P
Respiratory failure 38 (85.7%) 104 (51.1%) 0.0001
ALI 14 (33.3%) 43 (24.0%)                 NS
ARDS 9 (21.4%) 12 (6.7%) 0.007
Pulmonary embolism 2 (4.8%) 0 (0.0%) 0.035
SIRS/sepsis 35 (83.3%) 79 (44.1%) 0.0001
Shock due to SIRS/sepsis 28 (68.3%) 30 (16.8%) 0.0001
Infectious complications 18 (42.9%) 50 (27.9%)                 NS
Blood stream infection 10 (23.8%) 20 (11.2%) 0.031
Pneumonia 16 (38.1%) 49 (27.4%)                 NS
Urinary tract infection 3 (7.1%) 5 (2.8%)                   NS
Data are reported as number of patients, with percent given in parentheses. Total
number of patients = 221. Pearsons’ χ2 test. ARF = acute renal failure; ALI = acute
lung injury; ARDS = acute respiratory distress syndrome; SIRS = systemic inflamma-
tory response syndrome; NS = not significant.
Table 3. Risk factors associated with the development of acute renal failure (ARF)
identified by multivariate analysis.
Characteristics OR CI (95%)
Total population (N = 221)
Heart rate on admission 1.023 1.002-1.044
Male gender 4.275 1.340-13.642
Shock due to SIRS/sepsis 8.590 2.710-27.229
Intraoperative hydration 1.002 1.000-1.004NS
Urea on admission 1.012 0.980-1.044
Surgical patients (N = 160)
Heart rate on admission 1.025 1.004-1.047
Male gender 3.943 1.235-12.590
Shock due to SIRS/sepsis 9.421 2.912-30.480
Intra-operative hydration 1.002 1.000-1.004NS
Urea on admission 1.011 0.979-1.044NS
Multiple regression, OR = odds ratio; CI = confidence interval (95%); SIRS = systemic
inflammatory response syndrome.
NSNot significant.
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magnitude of the problem may have been
underestimated.
The unit where the study was conducted
is predominantly surgical, with a consequent
basically very complicated postoperative
population, since the inclusion only of pa-
tients with more than 48 h of ICU admission
excluded the majority of uncomplicated elec-
tive surgical patients. The mean hospital
stay prior to admission was long, with a high
frequency of associated co-morbidities.
These overlapping factors characterized a
high-risk population, explaining the high
mortality of the ARF patients studied. There
is a wide range of reported mortality rates
and this could be secondary to a wide varia-
tion in patient characteristics and practice
patterns across institutions.
However, the mean APACHE II score
and its respective death risk were relatively
low compared to other studies. There was a
difference between predicted and real mor-
tality suggesting that this index is not appro-
priate for ARF assessment. This finding has
been reported previously (28,29). On the
other hand, LODS score on the first ICU
admission day has proved to be very suitable
for mortality assessment. It is possible that
the first 24 h of admission do not define so
clearly the prognosis in the population with
ARF as the severity of organ dysfunction of
these patients would do.
Our results show that men were more
affected than women, presenting a 4-fold
higher risk (OR = 4.275). This was an inter-
esting finding since male gender and shock
were the variables with strongest association
with ARF in multivariate analysis. This find-
ing has also been reported by others (13).
The greater number of surgical complica-
tions, such as hypotension and bleeding as
well as the presence of previous coronary
heart disease and acute myocardial infarc-
tion may have contributed to this finding.
Differences related to gender are common in
the population of critically ill patients. For
instance, it has been shown that sepsis is
Table 5. Univariate analysis of risk factors for mortality of patients with acute renal
failure.
Characteristic Survivors Non-survivors P
(N = 10) (N = 32)
Shock due to SIRS/sepsis 1 (11.1%) 27 (84.4%) 0.0001
Respiratory failure 6 (60.0%) 30 (93.7%) 0.021
Blood stream infection 0 (0.0%) 10 (31.3%) 0.084
Use of noradrenaline 1 (10.0%) 14 (43.7%) 0.068
Plasma bicarbonate levels (mEq/L) 18.4 ± 3.8 15.3 ± 4.1 0.037
Plasma potassium levels (mEq/L) 5.0 ± 1.0 6.0 ± 0.8 0.013
Male gender 5 (50.0%) 20 (62.5%) NS
Chronic diseases 7 (70.0%) 21 (65.6%) NS
Surgical complications 4 (44.4%) 11 (47.8%) NS
Clinical complications 9 (90.0%) 32 (100.0%) NS
Infectious complications 2 (11.1%) 16 (88.9%) NS
SIRS/sepsis 7 (20.0%) 28 (80.0%) NS
ARDS 1 (10.0%) 8 (25.0%) NS
Use of dobutamine 2 (20.0%) 5 (15.6%) NS
Use of dopamine 3 (30.0%) 17 (53.1%) NS
Need for hemodyalisis 0 (0.0%) 9 (28.1%) NS
Age (years) 58.80 ± 19.57 54.16 ± 18.17 NS
Urea levels at admission (mg/dL) 42.23 ± 19.43 38.14 ± 18.22 NS
Lower PaO2/FiO2 rate 351.63 ± 264.41 310.50 ± 127.95 NS
Creatinine levels at admission (mg/dL) 1.04 ± 0.25 1.04 ± 0.43 NS
ICU stay (days) 19.50 ± 18.42 15.09 ± 11.51 NS
Hospital stay before ICU (days) 10.88 ± 10.47 8.03 ± 7.70 NS
APACHE II score 17.94 ± 9.23 15.75 ± 10.33 NS
1st day LODS score 6.60 ± 3.95 6.44 ± 3.37 NS
7th day LODS score 8.16 ± 2.40 11.80 ± 5.13 NS
Duration of abnormal creatinine (days) 7.80 ± 9.86 7.78 ± 8.07 NS
Levels of creatinine (mg/dL) 3.03 ± 2.10 3.39 ± 1.72 NS
Urine output post-ARF (mL/kg) 235.77 ± 302.63 215.98 ± 255.18 NS
Diuretic use (number of vials) 4.00 ± 4.24 13.71 ± 22.84 NS
Data are reported as means ± SD or as number of patients, with percent given in
parentheses. SIRS = systemic inflammatory response syndrome; ARDS = acute
respiratory distress syndrome; PaO2/FiO2 = arterial O2 partial pressure/inspired pres-
sure of O2; ICU = intensive care unit; APACHE II = Acute Physiology, Age and Chronic
Health Physiology Evaluation II; LODS = logistic organ dysfunction system; ARF =
acute renal failure. All variables with P < 0.1 were selected for multivariate analysis.
NS = not significant.
adopted here was based on a rather wide
definition, with high sensitivity, in order to
detect as large a number of patients as pos-
sible. Based on this definition, we found an
incidence of 19.0%, which agrees with stud-
ies in similar populations (3,8,13,15,17).
Within the inclusion criteria, patients with
previous renal dysfunction were not evalu-
ated in order to obtain the real incidence of
ARF inside the ICU. Thus, we tried to disre-
gard all patients who presented worsening of
chronic renal failure. Therefore, the real
1345
Braz J Med Biol Res 39(10) 2006
Acute renal failure in patients in an intensive care unit
more frequent among men (30) and renal
failure is part of the organ dysfunction con-
text in sepsis. It is also possible that still
unknown genetic aspects may have influ-
enced the incidence of ARF in the male
population.
Few studies have assessed the impact of
surgical complications on ARF development,
in spite of their potential as risk factors (31-
33). The mean volume replacement during
the intraoperative period among the patients
that developed ARF was higher than in the
patients that did not, and this factor remained
as an independent risk factor in multivariate
analysis, although with a low OR. Higher
intraoperative hydration can be a marker of
disease severity, since more severely ill pa-
tients need more fluid during surgery. On the
other hand, giving fluids to the surgical pa-
tient can by itself increase morbidity. Inter-
stitial edema is a concern in this population
as it predisposes to suture dehiscence, with
wounds being less prone to healing. Our
study was not designed to address this ques-
tion, and therefore only an association can
be considered with no causality assessment.
Although it did not remain in the multi-
variate analysis, the small difference in creati-
nine levels on admission in these two popu-
lations was highly significant (P = 0.0007).
Hypotension or hypovolemia could have
contributed. This fact may have clinical im-
plications since a surgical patient admitted
to the ICU with slightly elevated creatinine
levels must be considered and treated as a
patient at risk to develop ARF.
Like other investigators (5,6,8), we found
shock due to SIRS/sepsis as a risk factor
associated with ARF development both in
the group as a whole and in the subgroup of
surgical patients. Although resulting hypo-
tension is the most quoted factor, not all
pathophysiologic mechanisms of sepsis are
clear, and therefore the relationship with
ARF development is still a matter of discus-
sion (34,35). The absence of correlation with
the use of nephrotoxic drugs may suggest
that pre-renal causes are the leading patho-
physiological phenomena. These results
strengthen the fundamental role of hemody-
namic instability in the onset of ARF within
the organ dysfunction context of a patient
with sepsis or with an inflammatory response
secondary to other aggression agents.
Among the prognostic factors, four were
associated with a worse outcome of patients
with ARF: shock due to SIRS/sepsis, respi-
ratory failure with mechanical ventilation,
plasma bicarbonate levels, and maximum
plasma potassium levels. The only variable
that remained significant in the multivariate
analysis was the maximum plasma potas-
sium level. This suggests that ARF serious-
ness assessed by this variable is a determi-
nant of the prognosis of these patients. How-
ever, this analysis may have been confounded
by the small number of patients in each
subgroup, which prevented logistic regres-
sion analysis.
The present study had some limitations.
Many patients with normal creatinine levels
during ICU stay could have been considered
to have ARF, if other criteria such as creati-
nine clearance had been used. Thus, the real
incidence of ARF may have been under-
reported here. There is also the same prob-
lem regarding our inclusion criteria since
patients already with ARF but with normal
creatinine levels on admission could have
been included. It is well known that ARF can
be present in patients with normal creatinine
levels, mostly middle-aged or elderly pa-
tients. Thus, strictly speaking, our incidence
of ARF cannot be considered as the true
incidence in patients with previous normal
renal function, since several patients in our
sample could have, in fact, mild or moderate
chronic renal failure if estimated by creati-
nine clearance. Nonetheless, there is no con-
sensus in the literature regarding ARF defi-
nition and all other criteria, even calculated
or measured creatinine clearance, have their
own limitations.
Another limitation of our study is the low
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OR observed during multivariate analysis.
Despite a significant P value, the clinical
significance of these results is questionable.
Moreover, the confidence intervals fre-
quently involved the unit (1.0), such as intra-
operative hydration, urea levels on admis-
sion and even heart rate on admission (1.002-
1.044), which could compromise the strength
of our results. It is possible that our small
sample size (221) is responsible for these
low intervals. For this reason, our results
should be interpreted with caution.
There is a high incidence of ARF in ICU
patients who do not present it on admission,
with a high mortality rate. Risk and prognos-
tic factors are primarily related to hemody-
namic status. The global knowledge of the
factors involved in the onset and prognosis
of ARF is of fundamental importance re-
garding the management of critically ill pa-
tients. The high mortality associated with
this organ dysfunction causes it to be some-
what more feared than other dysfunctions,
such as acute respiratory distress syndrome,
disseminated intravascular coagulation or
even septic shock itself.
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